Cargando…
The Efficacy of the Prophylactic Use of Octreotide after a Pancreaticoduodenectomy
This study was performed to analyze the efficacy of the prophylactic use of octreotide (Novartis, Stein, Switzerland) for pancreatic fistula following a pancreaticoduodenectomy. The medical records of 190 patients who underwent a pancreaticoduodenectomy at the Samsung Medical Center in Seoul, Korea...
Autores principales: | Moon, Hyoun Jong, Heo, Jin Seok, Choi, Seong Ho, Joh, Jae Won, Choi, Dong Wook, Kim, Yong Il |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Yonsei University College of Medicine
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2810592/ https://www.ncbi.nlm.nih.gov/pubmed/16385654 http://dx.doi.org/10.3349/ymj.2005.46.6.788 |
Ejemplares similares
-
Outcomes of pancreaticoduodenectomy in patients with metastatic cancer
por: Kwak, Joo Hwa, et al.
Publicado: (2014) -
Pancreaticoduodenectomy for secondary periampullary cancer following extrahepatic bile duct cancer resection
por: Kim, Dong Hun, et al.
Publicado: (2014) -
Division of surgeon workload in pancreaticoduodenectomy: striving to decrease post‐operative pancreatic fistula
por: Kim, Dong Hun, et al.
Publicado: (2015) -
Prophylactic octreotide for postoperative pancreatic fistula in patients with pancreatoduodenectomy: Risk-stratified analysis
por: Yoon, So Jeong, et al.
Publicado: (2022) -
The Role of Prophylactic Octreotide Following Pancreaticoduodenectomy to Prevent Postoperative Pancreatic Fistula: A Meta-Analysis of the Randomized Controlled Trials
por: Garg, Pankaj Kumar, et al.
Publicado: (2018)